Insider Shareholders with Direct Ownership of Atai Life Sciences N.V. (ATAI)
ATAI Quotes by TradingView
This section provides a comprehensive overview of the insiders with direct ownership of Atai Life Sciences N.V. (ATAI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ATAI Life Sciences N.V. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
| 480,000 | 151,303 | 328,697 $466,749 | 5 |
May 16, 2024
Reduced 31.52%
|
|
| 350,000 | 137,058 | 212,942 $302,377 | 4 |
Mar 21, 2025
Reduced 26.15%
|
|
|
Anne Nagengast Johnson
Chief Financial Officer |
200,000 | 60,955 | 140,045 $198,863 | 4 |
Mar 21, 2025
Reduced 19.32%
|
|
Sahil Kirpekar
Chief Business Officer |
200,000 | 84,364 | 115,636 $164,203 | 4 |
Mar 21, 2025
Reduced 29.58%
|
|
Glenn Frank Short
Chief Scientific Officer |
32,500 | 13,161 | 42,333 $60,112 | 2 |
Mar 21, 2025
Reduced 23.72%
|
|
Kevin James Craig
Chief Medical Officer |
20,000 | 11,563 | 8,437 $11,980 | 2 |
Mar 21, 2025
Reduced 57.82%
|
| 4,666 | 0 | 4,666 $6,625 | 1 |
Jun 22, 2021
Added 50.0%
|
|
| 4,666 | 0 | 4,666 $6,625 | 1 |
Jun 22, 2021
Added 50.0%
|
|
|
Alexis De Rosnay
Director |
4,666 | 0 | 4,666 $6,625 | 1 |
Jun 22, 2021
Added 50.0%
|
|
Gregory L Weaver
Chief Financial Officer |
4,666 | 0 | 4,666 $6,625 | 1 |
Jun 22, 2021
Added 50.0%
|
Showing 1 to 10 of 10 entries